Nattopharma
NattoPharma Launches New Brand Identity, Website
NattoPharma’s (Oslo, Norway & East Brunswick, NJ) scientific leadership created the vitamin K2 category more than 20 years ago and has continued to shape the understanding of this nutrient’s benefits. As the research takes shape confirming vitamin K2’s expanding role supporting other overall health, NattoPharma has introduced its new logo, brand identity and website. “Our ...
New Study Confirms Vitamin K Status Marker Link to Cardio Risk
Clinical Biochemistry recently published a Danish population study that examined the link between inactive matrix Gla protein (MGP), a known biomarker for K-vitamins status, and cardiovascular risk and concluded that high levels of this inactive protein were positively associated with a history of cardiovascular disease (CVD) due to the role vitamin K2 plays in vascular ...
NattoPharma Spearheading Vitamin K2 RDI Program
Global cardiovascular and bone health has been negatively impacted by widespread vitamin K2 deficiency. Yet there is no established RDI (recommended daily intake) for vitamin K2. To that end, as a leader in vitamin K2, NattoPharma has enlisted its research partners to start a program to establish an RDI for vitamin K2. The program will ...
NattoPharma & Ortho Molecular Products Form Exclusive Partnership
NattoPharma (Oslo, Norway) has announced that it has been selected by Ortho Molecular Products, a leader in practitioner-specific nutraceuticals, as its exclusive vitamin K2 supplier partner. The company will transition the seven products in its line currently featuring vitamin K2 to MenaQ7 PRO, a line extension available only to Ortho Molecular. For more than 25 ...
Calcium, Vitamin K and Bone Health
According to Eric Anderson, senior vice president of global sales and marketing, with New Jersey-based NattoPharma USA Inc., there are two major challenges to overcome in the bone, muscle and joint health category. “The first is the ongoing media coverage of studies showing that excessive calcium supplementation can negatively impact cardiovascular health. These studies are ...
NattoPharma Partners With Glanbia for MenaQ7 PURE Distribution
Høvik, Norway-based Nattopharma ASA announced its exclusive distribution agreement with Glanbia Nutritionals, whereby NattoPharma’s new ingredient, MenaQ7 PURE will be distributed throughout the United States and Canada by Glanbia Nutritionals. Hogne Vik, CEO, NattoPharma said MenaQ7 PURE is the newest offering to Glanbia Nutritionals’ arsenal of unique, proprietary, branded, clinically substantiated, and validated ingredients.”The market ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
